BioSpace News Archive

Duchesnay USA, a pharmaceutical company that specializes in women’s health, is pleased to announce the launch of the new Osphena® (ospemifene) website

Target Group Inc. (“Target Group” or the “Company”) (OTCQB: CBDY) is pleased to announce, that effective August 8, 2019, it has entered into an exclusive licensing, manufacturing and distribution agreement with cGreen Inc. for a period of 10 years.

Compulink Healthcare Solutions is excited to announce the acquisition of MyEyeStore, an e-commerce solution in ophthalmic healthcare focusing primarily on contact lens re-ordering with the ability for optometry and ophthalmology practices to also sell other recommended products directly to the patient.

Biodesix, Inc., a leading lung cancer diagnostic solutions company, today announced the appointment of Robert W. Georgantas III Ph.D. as the company’s Senior Vice President (SVP) of Research and Translational Science.

ivWatch, a biosensor technology company focused on improving patient safety and the effectiveness of intravenous (IV) therapy, will participate in the ribbon-cutting celebration at 10:30 a.m. on August 16, 2019 for the opening of Tech Center Research Park’s Building One

Kidneys work to constantly filter blood and remove toxins from the body. Conditions such as chronic kidney disease (CKD) are characterized by a reduced ability to perform this essential function. CKD incidence is growing and more than 1.4 million individuals depend on dialysis or kidney transplant for survival

Asthma is underdiagnosed and undertreated in older Americans, leading to poor outcomes. Older asthma patients who also suffer from depression have double the rates of hospitalization than those without depression.

CereHealth Corporation, announced today that it has entered into a long-term agreement with Bioscience Pharma Partners, LLC (BPP) to provide clinical research, data analytics support and consulting services in connection with BPP’s clinical investigation and research initiatives.

Humania Assurance is proud to announce the acquisition of all of Tour+Med’s assets. Created by Mr. Daniel Provencher in 1996, the company providing Tour+Med travel insurance products has an administrative centre in Trois-Rivières, Quebec, and an assistance subsidiary in Florida, USA.

Bio-Techne Corporation and Cygnus Technologies, part of Maravai LifeSciences, announced today a strategic partnership for the quantification of Chinese hamster ovary host cell proteins (CHO-HCP) on the ProteinSimple™-branded Ella™ immunoassay platform.